Skip to content

Legal status · Canada

Is Sodium phenylbutyrate legal in Canada?

Written by Reviewed Sep 2026

ApprovedLongevityNo human studies cited

Direct answer

Yes. Sodium phenylbutyrate is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.

Sodium phenylbutyrate in Canada at a glance

ClassificationHealth Canada approved, prescription only
Health Canada approval statusApproved by Health Canada for its labeled use
Human studies cited0 of 1 citations on the profile
ReviewedSep 2026

Classification and note come from the Sodium phenylbutyrate profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.

What this means

  • 01

    Health Canada has approved Sodium phenylbutyrate for at least one labeled indication, so a pharmaceutical-grade product exists in Canada and is dispensed on prescription.

  • 02

    Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

  • 03

    Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Sodium phenylbutyrate is

A chemical chaperone that relieves endoplasmic reticulum stress, and a weak HDAC inhibitor, so it targeted two ageing mechanisms at once. It did not extend mouse lifespan in either sex.

This compound was an attractive candidate because it hits two things on the standard list of ageing hallmarks. Loss of proteostasis is one, and 4-phenylbutyrate is a chemical chaperone that helps misfolded proteins fold and relieves endoplasmic reticulum stress.

Mechanism: Two established activities. As a chemical chaperone it stabilises protein folding intermediates non-specifically and reduces the unfolded protein response, which is the basis of its use in conditions of protein misfolding.

Regulatory history: FDA-approved for urea cycle disorders. Also formed part of a combination product approved for amyotrophic lateral sclerosis that was subsequently withdrawn after its confirmatory trial failed. No ageing indication.

How Health Canada treats this kind of product

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Sodium phenylbutyrate at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Sodium phenylbutyrate in other countries

Frequently asked questions

Is Sodium phenylbutyrate legal in Canada?

Yes. Sodium phenylbutyrate is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.

Can I buy Sodium phenylbutyrate in Canada?

Only with a prescription. Sodium phenylbutyrate is classified as "Health Canada approved, prescription only" in Canada, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.

Is Sodium phenylbutyrate Health Canada approved?

Yes, for its labeled indication. In Canada Sodium phenylbutyrate is classified as "Health Canada approved, prescription only". For comparison, the US FDA status is: FDA-approved for urea cycle disorders. Also formed part of a combination product approved for amyotrophic lateral sclerosis that was subsequently withdrawn after its confirmatory trial failed. No ageing indication.. On the evidence, no human study is cited on its profile.

Related compounds in Canada

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Sodium phenylbutyrate live on its compound profile.

Sodium phenylbutyrate profile

This page is general information about the regulatory status of Sodium phenylbutyrate in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.